Beckman Coulter Diagnostics has unveiled its new DxC 500 AU, an automated clinical chemistry analyser. The DxC 500 AU is one of several recent Beckman Coulter solutions designed to address the complete needs of healthcare systems looking to complement central hub laboratories by advancing the capabilities of satellite and independent hospital laboratories.
The new analyser advances the capabilities of spoked laboratories with a broad menu of high-quality assays that deliver consistent, commutable results across Beckman Coulter’s AU clinical chemistry systems, positively impacting clinical decision-making.
The DxC 500 AU Chemistry Analyser features advanced automation technology, onboard guided workflows, and standardised reagents. Its menu of over 120 assays has been independently and objectively verified for high-quality Six Sigma performance, supporting confidence in clinical results while minimising QC troubleshooting, and operational costs.
E: [email protected]
W: www.beckmancoulter.com